126 related articles for article (PubMed ID: 28226310)
1. Adhesion of ligand-conjugated biosynthesized magnetite nanoparticles to triple negative breast cancer cells.
Obayemi JD; Hu J; Uzonwanne VO; Odusanya OS; Malatesta K; Anuku N; Soboyejo WO
J Mech Behav Biomed Mater; 2017 Apr; 68():276-286. PubMed ID: 28226310
[TBL] [Abstract][Full Text] [Related]
2. Enhanced cellular uptake of LHRH-conjugated PEG-coated magnetite nanoparticles for specific targeting of triple negative breast cancer cells.
Hu J; Obayemi JD; Malatesta K; Košmrlj A; Soboyejo WO
Mater Sci Eng C Mater Biol Appl; 2018 Jul; 88():32-45. PubMed ID: 29636136
[TBL] [Abstract][Full Text] [Related]
3. Investigation of adhesive interactions in the specific targeting of Triptorelin-conjugated PEG-coated magnetite nanoparticles to breast cancer cells.
Hu J; Youssefian S; Obayemi J; Malatesta K; Rahbar N; Soboyejo W
Acta Biomater; 2018 Apr; 71():363-378. PubMed ID: 29458110
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of the adhesion of biosynthesized gold and conjugated gold/prodigiosin nanoparticles to triple negative breast cancer cells.
Dozie-Nwachukwu SO; Obayemi JD; Danyuo Y; Anuku N; Odusanya OS; Malatesta K; Soboyejo WO
J Mater Sci Mater Med; 2017 Aug; 28(9):143. PubMed ID: 28819929
[TBL] [Abstract][Full Text] [Related]
5. Adhesion of LHRH/EphA2 to human Triple Negative Breast Cancer tissues.
Ezenwafor TC; Uzonwanne VO; Madukwe JUA; Amin SM; Anye VC; Obayemi JD; Odusanya OS; Soboyejo WO
J Mech Behav Biomed Mater; 2022 Dec; 136():105461. PubMed ID: 36195050
[TBL] [Abstract][Full Text] [Related]
6. Biosynthesis and the conjugation of magnetite nanoparticles with luteinizing hormone releasing hormone (LHRH).
Obayemi JD; Dozie-Nwachukwu S; Danyuo Y; Odusanya OS; Anuku N; Malatesta K; Soboyejo WO
Mater Sci Eng C Mater Biol Appl; 2015 Jan; 46():482-96. PubMed ID: 25492013
[TBL] [Abstract][Full Text] [Related]
7. LHRH-Conjugated Drugs as Targeted Therapeutic Agents for the Specific Targeting and Localized Treatment of Triple Negative Breast Cancer.
Obayemi JD; Salifu AA; Eluu SC; Uzonwanne VO; Jusu SM; Nwazojie CC; Onyekanne CE; Ojelabi O; Payne L; Moore CM; King JA; Soboyejo WO
Sci Rep; 2020 May; 10(1):8212. PubMed ID: 32427904
[TBL] [Abstract][Full Text] [Related]
8. Triptorelin-functionalized PEG-coated biosynthesized gold nanoparticles: Effects of receptor-ligand interactions on adhesion to triple negative breast cancer cells.
Uzonwanne VO; Navabi A; Obayemi JD; Hu J; Salifu AA; Ghahremani S; Ndahiro N; Rahbar N; Soboyejo W
Biomater Adv; 2022 May; 136():212801. PubMed ID: 35929297
[TBL] [Abstract][Full Text] [Related]
9. Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125.
Seitz S; Buchholz S; Schally AV; Weber F; Klinkhammer-Schalke M; Inwald EC; Perez R; Rick FG; Szalontay L; Hohla F; Segerer S; Kwok CW; Ortmann O; Engel JB
BMC Cancer; 2014 Nov; 14():847. PubMed ID: 25410881
[TBL] [Abstract][Full Text] [Related]
10. pH-Dependent Adsorption Release of Doxorubicin on MamC-Biomimetic Magnetite Nanoparticles.
García Rubia G; Peigneux A; Jabalera Y; Puerma J; Oltolina F; Elert K; Colangelo D; Gómez Morales J; Prat M; Jimenez-Lopez C
Langmuir; 2018 Nov; 34(45):13713-13724. PubMed ID: 30394747
[TBL] [Abstract][Full Text] [Related]
11. Targeted chemotherapy for triple-negative breast cancers via LHRH receptor.
Föst C; Duwe F; Hellriegel M; Schweyer S; Emons G; Gründker C
Oncol Rep; 2011 May; 25(5):1481-7. PubMed ID: 21331448
[TBL] [Abstract][Full Text] [Related]
12. In-vivo studies of targeted and localized cancer drug release from microporous poly-di-methyl-siloxane (PDMS) devices for the treatment of triple negative breast cancer.
Eluu SC; Obayemi JD; Salifu AA; Yiporo D; Oko AO; Aina T; Oparah JC; Ezeala CC; Etinosa PO; Ugwu CM; Esimone CO; Soboyejo WO
Sci Rep; 2024 Jan; 14(1):31. PubMed ID: 38167999
[TBL] [Abstract][Full Text] [Related]
13. LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases.
Leuschner C; Kumar CS; Hansel W; Soboyejo W; Zhou J; Hormes J
Breast Cancer Res Treat; 2006 Sep; 99(2):163-76. PubMed ID: 16752077
[TBL] [Abstract][Full Text] [Related]
14. Pt-Mal-LHRH, a Newly Synthesized Compound Attenuating Breast Cancer Tumor Growth and Metastasis by Targeting Overexpression of the LHRH Receptor.
Calderon LE; Keeling JK; Rollins J; Black CA; Collins K; Arnold N; Vance DE; Ndinguri MW
Bioconjug Chem; 2017 Feb; 28(2):461-470. PubMed ID: 27997127
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparticles suppresses breast cancer growth and metastasis.
Li M; Tang Z; Zhang Y; Lv S; Li Q; Chen X
Acta Biomater; 2015 May; 18():132-43. PubMed ID: 25735801
[TBL] [Abstract][Full Text] [Related]
16. Anti-Trop2 antibody-conjugated bioreducible nanoparticles for targeted triple negative breast cancer therapy.
Son S; Shin S; Rao NV; Um W; Jeon J; Ko H; Deepagan VG; Kwon S; Lee JY; Park JH
Int J Biol Macromol; 2018 Apr; 110():406-415. PubMed ID: 29055700
[TBL] [Abstract][Full Text] [Related]
17. The importance of cell uptake in photothermal treatments mediated by biomimetic magnetic nanoparticles.
Lázaro M; Lupiáñez P; Sola-Leyva A; Pozo-Gualda T; Oltolina F; Jimenez-Carretero M; Jimenez-Lopez C; Carrasco-Jiménez MP; Iglesias GR
Colloids Surf B Biointerfaces; 2024 Feb; 234():113722. PubMed ID: 38160473
[TBL] [Abstract][Full Text] [Related]
18. c-erbB-2 as a possible target for the use of magnetic nanoparticles in breast cancer cells.
Silva-Escobedo JG; Sanchez-Monroy V; Rojas-Lopez M; Lopez-Cruz J; González CA
IEEE Trans Nanobioscience; 2014 Sep; 13(3):300-7. PubMed ID: 25014961
[TBL] [Abstract][Full Text] [Related]
19. A Comparative Study of Receptor-Targeted Magnetosome and HSA-Coated Iron Oxide Nanoparticles as MRI Contrast-Enhancing Agent in Animal Cancer Model.
Erdal E; Demirbilek M; Yeh Y; Akbal Ö; Ruff L; Bozkurt D; Cabuk A; Senel Y; Gumuskaya B; Algın O; Colak S; Esener S; Denkbas EB
Appl Biochem Biotechnol; 2018 May; 185(1):91-113. PubMed ID: 29082480
[TBL] [Abstract][Full Text] [Related]
20. Biosynthesized magnetite nanoparticles as an environmental opulence and sustainable wastewater treatment.
El-Gendy NS; Nassar HN
Sci Total Environ; 2021 Jun; 774():145610. PubMed ID: 33609818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
